218 related articles for article (PubMed ID: 29258771)
21. Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds.
Kaptein SJF; Vincetti P; Crespan E; Rivera JIA; Costantino G; Maga G; Neyts J; Radi M
ChemMedChem; 2018 Jul; 13(14):1371-1376. PubMed ID: 29740962
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of zika virus infection by fused tricyclic derivatives of 1,2,4,5-tetrahydroimidazo[1,5-a]quinolin-3(3aH)-one.
Xu B; Lee EM; Medina A; Sun X; Wang D; Tang H; Zhou GC
Bioorg Chem; 2020 Nov; 104():104205. PubMed ID: 32916389
[TBL] [Abstract][Full Text] [Related]
23. Drug Repurposing: New Treatments for Zika Virus Infection?
Cheng F; Murray JL; Rubin DH
Trends Mol Med; 2016 Nov; 22(11):919-921. PubMed ID: 27692879
[TBL] [Abstract][Full Text] [Related]
24. The A-Z of Zika drug discovery.
Mottin M; Borba JVVB; Braga RC; Torres PHM; Martini MC; Proenca-Modena JL; Judice CC; Costa FTM; Ekins S; Perryman AL; Horta Andrade C
Drug Discov Today; 2018 Nov; 23(11):1833-1847. PubMed ID: 29935345
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Snyder B; Goebel S; Koide F; Ptak R; Kalkeri R
J Med Virol; 2018 Jan; 90(1):8-12. PubMed ID: 28851097
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic targets and biological mechanisms of action of curcumin against Zika virus: In silico and in vitro analyses.
Kim M; Choi H; Kim YB
Eur J Pharmacol; 2021 Aug; 904():174144. PubMed ID: 33957087
[TBL] [Abstract][Full Text] [Related]
27. Future and Perspectives of the Zika Virus: Drug Repurposing as a Powerful Tool for Treatment Insights.
Rampini D; Prieto DC; Colzi AL; de Araújo RV; Giarolla J
Mini Rev Med Chem; 2020; 20(18):1917-1928. PubMed ID: 32651967
[TBL] [Abstract][Full Text] [Related]
28. Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids.
Pettke A; Tampere M; Pronk R; Wallner O; Falk A; Warpman Berglund U; Helleday T; Mirazimi A; Puumalainen MR
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383826
[TBL] [Abstract][Full Text] [Related]
29. Repurposing drugs for use against Zika virus infection.
Devillers J
SAR QSAR Environ Res; 2018 Feb; 29(2):103-115. PubMed ID: 29299939
[TBL] [Abstract][Full Text] [Related]
30. Strategies for Zika drug discovery.
Zou J; Shi PY
Curr Opin Virol; 2019 Apr; 35():19-26. PubMed ID: 30852345
[TBL] [Abstract][Full Text] [Related]
31. A Review of the Ongoing Research on Zika Virus Treatment.
da Silva S; Oliveira Silva Martins D; Jardim ACG
Viruses; 2018 May; 10(5):. PubMed ID: 29758005
[TBL] [Abstract][Full Text] [Related]
32. Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors.
Zhu S; Zhang C; Huang LS; Zhang XQ; Xu Y; Fang X; Zhou J; Wu M; Schooley RT; Huang Z; An J
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013906
[TBL] [Abstract][Full Text] [Related]
33. Antiviral activity of lycorine against Zika virus in vivo and in vitro.
Chen H; Lao Z; Xu J; Li Z; Long H; Li D; Lin L; Liu X; Yu L; Liu W; Li G; Wu J
Virology; 2020 Jul; 546():88-97. PubMed ID: 32452420
[TBL] [Abstract][Full Text] [Related]
34. Halogenated Chrysins Inhibit Dengue and Zika Virus Infectivity.
Suroengrit A; Yuttithamnon W; Srivarangkul P; Pankaew S; Kingkaew K; Chavasiri W; Boonyasuppayakorn S
Sci Rep; 2017 Oct; 7(1):13696. PubMed ID: 29057920
[TBL] [Abstract][Full Text] [Related]
35. Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus.
Martinez-Lopez A; Persaud M; Chavez MP; Zhang H; Rong L; Liu S; Wang TT; Sarafianos SG; Diaz-Griffero F
EBioMedicine; 2019 Sep; 47():269-283. PubMed ID: 31501074
[TBL] [Abstract][Full Text] [Related]
36. Editorial: Spilled Over Emerging Infectious Diseases Necessitate an Accelerated Drug Design and Discovery Program: Some Comments with Special Reference to Chemoinformatics and the Current Zika Virus Crisis.
Bhattacharjee AK; Basak SC
Curr Comput Aided Drug Des; 2016; 12(4):251-252. PubMed ID: 27682644
[No Abstract] [Full Text] [Related]
37. Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.
Cai L; Sun Y; Song Y; Xu L; Bei Z; Zhang D; Dou Y; Wang H
Arch Virol; 2017 Sep; 162(9):2847-2853. PubMed ID: 28597088
[TBL] [Abstract][Full Text] [Related]
38. The Polyphenol-Rich Extract from
Clain E; Haddad JG; Koishi AC; Sinigaglia L; Rachidi W; Desprès P; Duarte Dos Santos CN; Guiraud P; Jouvenet N; El Kalamouni C
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991717
[TBL] [Abstract][Full Text] [Related]
39. Bafilomycin A1 and U18666A Efficiently Impair ZIKV Infection.
Sabino C; Basic M; Bender D; Elgner F; Himmelsbach K; Hildt E
Viruses; 2019 Jun; 11(6):. PubMed ID: 31174294
[TBL] [Abstract][Full Text] [Related]
40. Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors.
Palanichamy K; Joshi A; Mehmetoglu-Gurbuz T; Bravo MF; Shlain MA; Schiro F; Naeem Y; Garg H; Braunschweig AB
J Med Chem; 2019 Apr; 62(8):4110-4119. PubMed ID: 30925051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
